These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15800911)

  • 21. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
    Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human testis-specific PDHA2 gene: methylation status of a CpG island in the open reading frame correlates with transcriptional activity.
    Pinheiro A; Faustino I; Silva MJ; Silva J; Sá R; Sousa M; Barros A; de Almeida IT; Rivera I
    Mol Genet Metab; 2010 Apr; 99(4):425-30. PubMed ID: 20005141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
    Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
    Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression.
    Newell-Price J; King P; Clark AJ
    Mol Endocrinol; 2001 Feb; 15(2):338-48. PubMed ID: 11158338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
    Guilleret I; Benhattar J
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
    Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
    Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
    Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells.
    Luo W; Wang X; Kageshita T; Wakasugi S; Karpf AR; Ferrone S
    Oncogene; 2006 May; 25(20):2873-84. PubMed ID: 16407841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R
    Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter demethylation mediates the expression of ZNF645, a novel cancer/testis gene.
    Bai G; Liu Y; Zhang H; Su D; Tao D; Yang Y; Ma Y; Zhang S
    BMB Rep; 2010 Jun; 43(6):400-6. PubMed ID: 20587329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells.
    Hisano M; Ohta H; Nishimune Y; Nozaki M
    Nucleic Acids Res; 2003 Aug; 31(16):4797-804. PubMed ID: 12907721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.